http://www.salisonline.org              Tel: +1-518-618-1030            sales@researchmoz.comNorth America In Vitro Diagno...
http://www.salisonline.org             Tel: +1-518-618-1030            sales@researchmoz.com- What are the key distributio...
http://www.salisonline.org         Tel: +1-518-618-1030   sales@researchmoz.com6.11 Qiagen N.V. 856.12 Gen-Probe Incorpora...
http://www.salisonline.org          Tel: +1-518-618-1030        sales@researchmoz.com10.10 Contact Us 74910.11 Disclaimer ...
http://www.salisonline.org         Tel: +1-518-618-1030        sales@researchmoz.com2010-2011 73Table 22: Infectious Immun...
http://www.salisonline.org           Tel: +1-518-618-1030        sales@researchmoz.comTable 44: Haematology Market Pipelin...
http://www.salisonline.org          Tel: +1-518-618-1030        sales@researchmoz.comTable 75: IntegenX Acquires SV, Provi...
http://www.salisonline.org          Tel: +1-518-618-1030         sales@researchmoz.comColon Cancer Markers 223Table 98: Ab...
http://www.salisonline.org          Tel: +1-518-618-1030         sales@researchmoz.comMitomic Test 248Table 120: Trillium ...
http://www.salisonline.org         Tel: +1-518-618-1030        sales@researchmoz.comFor GOBIOM Database 277Table 143: Gene...
http://www.salisonline.org          Tel: +1-518-618-1030        sales@researchmoz.comDiagnostic Tool 305Table 168: HTG Mol...
http://www.salisonline.org           Tel: +1-518-618-1030        sales@researchmoz.comTable 192: KineMed Enters Into Co-De...
http://www.salisonline.org          Tel: +1-518-618-1030         sales@researchmoz.comTable 217: ZyGem Enters Into Technol...
http://www.salisonline.org          Tel: +1-518-618-1030        sales@researchmoz.comTable 242: Shimadzu Scientific Instru...
http://www.salisonline.org          Tel: +1-518-618-1030         sales@researchmoz.comTechnology 423Table 266: Vital Diagn...
http://www.salisonline.org          Tel: +1-518-618-1030        sales@researchmoz.comGenetic Biomarkers And Potential Diag...
http://www.salisonline.org         Tel: +1-518-618-1030        sales@researchmoz.comFigure 23: Haematology, Canada, Compan...
Upcoming SlideShare
Loading in …5
×

North america in vitro diagnostics market outlook to 2018

542 views

Published on

GlobalDatas new report, North America In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the North America In Vitro Diagnostics market - Canada and United States. The report provides value (USD million) data for all the market categories

To read more .....http://www.salisonline.org/study/north-america-in-vitro-diagnostics-market-outlook-to-2018-clinical-chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-microbiology-culture.asp#discription-tab

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
542
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

North america in vitro diagnostics market outlook to 2018

  1. 1. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comNorth America In Vitro Diagnostics Market Outlook to 2018- Clinical ChemistryGenetic Testing, Haematology, Histology and Cytology, Immuno Chemistry,Infectious Immunology and Microbiology CultureSummaryGlobalData’s new report, North America In Vitro Diagnostics Market Outlook to 2018- ClinicalChemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, InfectiousImmunology and Microbiology Culture provides key market data on the North America In VitroDiagnostics market - Canada and United States. The report provides value (USD million) data for all themarket categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, ImmunoChemistry, Infectious Immunology and Microbiology Culture. The report also provides company sharesand distribution shares data for each of the aforementioned market categories. The report issupplemented with global corporate-level profiles of the key market participants.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalDatas team of industry experts.Scope- Countries covered include Canada and United States.- Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry,Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology andMicrobiology Culture.- Annualized market revenues (USD million) data for each of the market categories in each of thecountry. Data from 2004 to 2011, forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the market categories and countries.- Global corporate-level profiles of key companies operating within the North America In VitroDiagnostics market..- Key players covered include Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd.,Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., Alere Inc. and others.Reasons to buy- Develop business strategies by identifying the key market categories and segments poised for stronggrowth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the North America In VitroDiagnostics competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to registerstrong growth in the near future.
  2. 2. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com- What are the key distribution channels and what’s the most preferred mode of product distribution -Identify, understand and capitalize BUY NOWTable of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 152 Introduction 162.1 What is This Report About? 163 In Vitro Diagnostics in North America 173.1 In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, 2004-2018 173.2 In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, 2004-2018 183.3 In Vitro Diagnostics, North America, Company share (2010-2011) 264 In Vitro Diagnostics In United States 284.1 In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, 2004-2018 284.2 In Vitro Diagnostics, United States, Distribution Share (2010-2011) 344.3 In Vitro Diagnostics, United States, Company Share (2010-2011) 385 In Vitro Diagnostics In Canada 515.1 In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, 2004-2018 515.2 In Vitro Diagnostics, Canada, Distribution Share (2010-2011) 575.3 Clinical Chemistry Distribution Share (2010-2011) 575.4 In Vitro Diagnostics, Canada, Company Share (2010-2011) 615.5 Microbiology Culture, Canada, Company Share (2010-2011) 756 Overview of Key Companies in North America In Vitro Diagnostics 776.1 Siemens Healthcare 776.2 Abbott Laboratories 786.3 F. Hoffmann-La Roche Ltd. 796.4 Beckman Coulter, Inc. 806.5 Ortho-Clinical Diagnostics Inc. 816.6 Alere Inc. 826.7 bioMerieux S.A. 836.8 Becton, Dickinson and Company 836.9 Bio-Rad Laboratories, Inc. 846.10 Sysmex Corporation 84
  3. 3. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com6.11 Qiagen N.V. 856.12 Gen-Probe Incorporated 856.13 DiaSorin S.p.A 866.14 Immucor, Inc. 866.15 Thermo Fisher Scientific Inc. 876.16 Hologic, Inc. 876.17 Cepheid 886.18 PerkinElmer, Inc. 886.19 Grifols, S.A. 896.20 ELITech Group 896.21 Life Technologies Corporation 906.22 Horiba, Ltd. 906.23 Biomedica Diagnostics Inc. 916.24 Diagnostica Stago, Inc. 916.25 OraSure Technologies, Inc. 917 North America Market Pipeline Products 927.1 Clinical Chemisty Market Pipeline Products 927.2 Immuno Chemistry Market Pipeline Products 997.3 Haematology Market Pipeline Products 1107.4 Infectious Immunology Market Pipeline Products 1127.5 Microbiology Culture Market Pipeline Products 1197.6 Histology And Cytology Market Pipeline Products 1217.7 Genetic Testing Market Pipeline Products 1228 Financial Deals Landscape 1278.1 Acquisition 1278.2 Partnerships 1779 Recent Developments 4429.1 Strategy And Business Planning 4429.2 Research And Development 4749.3 Legal and Regulatory 4829.4 Government and Public Interest 5119.5 Product News 57210 Appendix 73410.1 Definitions of Markets Covered in the Report 73510.2 Research Methodology 74610.3 Secondary Research 74610.4 Primary Research 74710.5 Models 74710.6 Forecasts 74810.7 Expert Panels 74810.8 GlobalData Consulting 74810.9 Currency Conversion 749
  4. 4. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com10.10 Contact Us 74910.11 Disclaimer 7491.1 List of TablesTable 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 44Table 2: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, 2004-201846Table 3: In Vitro Diagnostics, North America, Cross-Category Analysis, 2004-2018 48Table 4: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, Historic,2004-2011 50Table 5: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, Forecast,2011-2018 52Table 6: In Vitro Diagnostics, North America, Company share by Revenue ($m), USD Constant,2010-2011 54Table 7: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, 2004-201856Table 8: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Historic,2004-2011 58Table 9: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Forecast,2011-2018 60Table 10: Clinical Chemistry, United States, Distribution Share by Revenue ($m), USDConstant, 2010-2011 61Table 11: Genetic Testing, United States, Distribution Share by Revenue ($m), USD Constant,2010-2011 61Table 12: Haematology, United States, Distribution Share by Revenue ($m), USD Constant,2010-2011 62Table 13: Histology And Cytology, United States, Distribution Share by Revenue ($m), USDConstant, 2010-2011 62Table 14: Immuno Chemistry, United States, Distribution Share by Revenue ($m), USDConstant, 2010-2011 63Table 15: Infectious Immunology, United States, Distribution Share by Revenue ($m), USDConstant, 2010-2011 63Table 16: Microbiology Culture, United States, Distribution Share by Revenue ($m), USDConstant, 2010-2011 64Table 17: In Vitro Diagnostics, United States, Company Share by Revenue ($m), USD Constant,2010-2011 66Table 18: Clinical Chemistry, United States, Company Share by Revenue ($m), USD Constant,2010-2011 67Table 19: Genetic Testing, United States, Company Share by Revenue ($m), USD Constant,2010-2011 69Table 20: Haematology, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 71Table 21: Immuno Chemistry, United States, Company Share by Revenue ($m), USD Constant,
  5. 5. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com2010-2011 73Table 22: Infectious Immunology, United States, Company Share by Revenue ($m), USDConstant, 2010-2011 75Table 23: Microbiology Culture, United States, Company Share by Revenue ($m), USDConstant, 2010-2011 77Table 24: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, 2004-2018 79Table 25: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 81Table 26: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 83Table 27: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), USD Constant,2010-2011 84Table 28: Genetic Testing, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 84Table 29: Haematology, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 85Table 30: Histology And Cytology, Canada, Distribution Share by Revenue ($m), USDConstant, 2010-2011 85Table 31: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), USD Constant,2010-2011 86Table 32: Infectious Immunology, Canada, Distribution Share by Revenue ($m), USD Constant,2010-2011 86Table 33: Microbiology Culture, Canada, Distribution Share by Revenue ($m), USD Constant,2010-2011 87Table 34: In Vitro Diagnostics, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 89Table 35: Clinical Chemistry, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 91Table 36: Genetic Testing, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 93Table 37: Haematology, Canada, Company Share by Revenue ($m), USD Constant, 2010-201195Table 38: Histology And Cytology, Canada, Company Share by Revenue ($m), USD Constant,2010-2011 97Table 39: Immuno Chemistry, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 99Table 40: Infectious Immunology, Canada, Company Share by Revenue ($m), USD Constant,2010-2011 101Table 41: Microbiology Culture, Canada, Company Share by Revenue ($m), USD Constant,2010-2011 103Table 42: Clinical Chemisty Market Pipeline Products 119Table 43: Immuno Chemistry Market Pipeline Products 126
  6. 6. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comTable 44: Haematology Market Pipeline Products 137Table 45: Infectious Immunology Market Pipeline Products 139Table 46: Microbiology Culture Market Pipeline Products 146Table 47: Histology And Cytology Market Pipeline Products 148Table 48: Genetic Testing Market Pipeline Products 149Table 49: SQI Diagnostics Plans For Sale Of The Company 154Table 50: Sparton Completes Acquisition Of Onyx EMS, Contract Manufacturing ServicesProvider, For $43 Million 155Table 51: ERBA Diagnostics Acquires Drew Scientific, Maker Of Analytical Instruments AndReagents, For $6.5 Million 157Table 52: Measurement Specialties Acquires Cambridge Technologies And ResistanceTemperature Detector Company For $18.8 Million 159Table 53: Atossa Genetics Acquires Acueity Healthcare, Diagnostic Device Provider 160Table 54: AccelPath Acquires DigiPath Solutions For $2.4 Million 161Table 55: Danaher Completes Acquisition Of 91.6% Stake In Iris International, Diagnostic TestMaker, For $324 Million 162Table 56: Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services,For $17 Million 164Table 57: Leica Biosystems Completes Acquisition Of Aperio Technologies 166Table 58: Metabolon Acquires Lipomics Technologies, Diagnostics Company 169Table 59: Waters Acquires Blue Reference, Maker Of Application Scientific Databases, For $14Million 171Table 60: Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 172Table 61: Thermo Fisher Scientific Completes Acquisition Of One Lambda, TransplantDiagnostics Company, For $925 Million 173Table 62: Life Technologies Acquires Navigenics 175Table 63: Genova Diagnostics Acquires Metametrix, Clinical Laboratory 177Table 64: 23andMe Acquires CureTogether, Healthcare IT Company 178Table 65: Luminex To Acquire GenturaDx, Molecular Diagnostics Company, For $50 Million179Table 66: Systagenix Acquires O2 Insights 181Table 67: Maxxam Analytics Acquires Becquerel Labs, Provider Of Testing Services 182Table 68: LabCorp Completes Acquisition Of Medtox Scientific For $241 Million 183Table 69: Flagship Biosciences Acquires Ihctech, Provider Of Research ImmunohistochemistryAnd Histology Services 185Table 70: Halo Healthcare Acquires NeoMatrix, Maker Of Diagnostic Equipments 186Table 71: Pacepartners To Acquire Vivione BioSciences 187Table 72: Qiagen Acquires AmniSure International, Manufacturer Of Non Invasive TestSolutions 188Table 73: Hologic Completes Acquisition Of Gen-Probe For $3.7 Billion 189Table 74: Haemonetics To Acquire Hemerus Medical, Provider Of LeukoreductionTechnologies, For $27 Million 192
  7. 7. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comTable 75: IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, FromGE Healthcare Bio-Sciences 194Table 76: Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 195Table 77: Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider,For $155 Million 196Table 78: Ontario Genomics Institute Acquires Minority Stake In RNA Diagnostics For $0.1Million 198Table 79: PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 199Table 80: Alere To Acquire eScreen, Provider Of Health Testing Products And Services, For UpTo $340 Million 200Table 81: Bode Technology Group Acquires Provider Of DNA Analysis Testing Services,Chromosomal Labs 202Table 82: Signal Genetics To Acquire Molecular Diagnostics Company, ChipDX 203Table 83: Multiple Myeloma Research Foundation Enters Into Co-Development AgreementWith GenoSpace 204Table 84: Empire Genomics Enters Into Licensing Agreement With Emory University ForGenomic Biomarkers 205Table 85: NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma ForMicronJet 206Table 86: Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs ForTranscreener Epigen Methyltransferase Assay 207Table 87: BioView Enters Into Agreement With Abbott To Develop Automated CancerScreening System 209Table 88: Institute of Microelectronics Enters Into Co-Development Agreement With SFCFluidics 210Table 89: HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre ofExcellence for Prevention of Organ Failure For COPD Prognostic Test 211Table 90: Pressure BioSciences Enters Into Co-Marketing Agreement With Constant SystemsFor High Pressure Technologies 212Table 91: CML HealthCare Enters Into Licensing Agreement With Mitomics For ProstateCancer Test 214Table 92: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology215Table 93: DioGenix Enters Into Agreement With Fast Forward To Develop New Blood Test ForMultiple Sclerosis 217Table 94: GNS Healthcare Enters Into Agreement With Dana-Farber Cancer Institute and MountSinai School of Medicine 219Table 95: Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery221Table 96: CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests222Table 97: Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For
  8. 8. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comColon Cancer Markers 223Table 98: Abaxis Enters Into Distribution Agreement With Abbott Point of Care For PiccoloBlood Chemistry System 224Table 99: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments ForArchimedes Particle Metrology System 226Table 100: Malvern Instruments Enters Into Co-Marketing Agreement With Affinity BiosensorsFor Archimedes Particle Metrology System 227Table 101: Exosome Diagnostics Enters Into Co-Development Agreement With Promega ForUrine Clinical Sample Concentrator Kit 228Table 102: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ229Table 103: Ezose Enters Into Co-Development Agreement With Fast Forward For MultipleSclerosis Biomarkers 230Table 104: BioDot Enters Into Co-Marketing Agreement With JOT Automation 231Table 105: Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology232Table 106: LifeTech Scientific, DiNova Venture Partners, Themes Investment Partners AndBroncus Technologies Partner To Form Broncus Medical 233Table 107: Van Andel Institute Enters Into Co-Development Agreement With Emory University235Table 108: Merck Serono Enters Into Co-Development Agreement With Auxogyn For EarlyEmbryo Viability Assessment Test 236Table 109: PGXL Labs Enters Into Joint Venture Agreement With Essential Molecular Testing237Table 110: Broad Institute Enters Into Distribution Agreement With Appistry For GenomeAnalysis Toolkit 238Table 111: Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 239Table 112: Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays240Table 113: Bruker Enters Into An Agreement With Nextval For High-throughput ScreeningTechnology 241Table 114: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop NewOncology Assays 242Table 115: RainDance Technologies Enters Into Co-Development Agreement With IntegratedDNA Technologies For Digital PCR 243Table 116: Amarantus BioSciences Enters Into Option For Licensing Agreement With MemoryDx For LymPro Blood Test 245Table 117: Iverson Genetic Diagnostics Enters Into Licensing Agreement With Johns HopkinsUniversity School For Molecular Diagnostic Tests 246Table 118: Rosetta Genomics Amends Co-Marketing Agreement With Precision TherapeuticsFor miRview mets2 Assays 247Table 119: Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core
  9. 9. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comMitomic Test 248Table 120: Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For SepsisDx 250Table 121: Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling AndDiagnostic Discovery 251Table 122: Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 252Table 123: Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For14-3-3n Biomarker 253Table 124: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For DigitalMicroscopy Hematology Solutions 254Table 125: Ingenuity Systems Enters Into Co-Development Agreement With Life TechnologiesFor Diagnostic Solutions 256Table 126: Med BioGene Amends Licensing Agreement With Precision Therapeutics ForLungExpress Dx Test 258Table 127: Genia Technologies Enters Into Co-Development Agreement With ColumbiaUniversity And Harvard University 260Table 128: NextBio Enters Into Agreement With Winship Cancer Institute of Emory UniversityFor Myeloma Biomarkers 262Table 129: Proof Centre Enters Into Co-Development Agreement With AllerGen For AllergyBiomarkers 263Table 130: Ovizio Imaging Systems Enters Into Distribution Agreement With ApplikonBiotechnology 264Table 131: Atossa Enters Into Co-Marketing Agreement With Diagnostics Test Group ForMASCT System 265Table 132: Genalyte Partners Scienion To Provide Sciflexarrayer Dispensers For MaverickDetection Platform 266Table 133: CML HealthCare Enters Into Agreement With MaRS Innovation 267Table 134: Life Technologies Enters Into Agreement With Bristol-Myers Squibb For CompanionDiagnostics Development 268Table 135: Agilent Technologies Enters Into Co-Marketing Agreement With MolecularDiscovery 269Table 136: Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics270Table 137: Castle Biosciences Enters Into Licensing Agreement With Brigham and WomensHospital For Mesothelioma Test 271Table 138: Illumina Enters Into Technology Integration Agreement With Partners HealthCareSystem 272Table 139: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing ForProtein Array Products 274Table 140: ImaginAb Enters Into Co-Development Agreement With MacroGenics 275Table 141: BellBrook Labs Enters Into Co-Development Agreement With Reaction Biology 276Table 142: GVK Biosciences Enters Into Licensing Agreement With National Cancer Institute
  10. 10. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comFor GOBIOM Database 277Table 143: GeneCentric Diagnostics Enters Into Licensing Agreement With University of NorthCarolina 278Table 144: Perkinelmer Enters Into Co-Development Agreement With Massachusetts GeneralHospital 279Table 145: Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 281Table 146: Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 282Table 147: University of Michigan Enters Into Joint Venture Agreement With InternationalGenomics Consortium 283Table 148: Regulus Therapeutics Enters Into An Agreement With Biogen Idec For Biomarkers284Table 149: Curetis Enters Into Licensing Agreement With Cempra For Unyvero 285Table 150: Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology286Table 151: Saladax Biomedical Expands Co-Development Agreement With Bristol-MyersSquibb 287Table 152: Epistem Enters Into Distribution Agreement With Becton Dickinson ForMycobacterium TB Test 288Table 153: Waters Enters Into Co-Development Agreement With Nonlinear Dynamics 289Table 154: Affymetrix Expands Licensing Agreement With Siemens Healthcare For BranchedDNA Technology 290Table 155: Molecular Targeting Technologies Enters Into Licensing Agreement With MedicalCollege of Wisconsin For 99mTc-HYNIC-Duramycin 291Table 156: Rosetta Genomics Enters Into Co-Marketing Agreement With Precision TherapeuticsFor miRview mets2 Assays 292Table 157: Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For MultiplexBiomarker Kits 294Table 158: Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 295Table 159: OriGene Technologies Enters Into Co-Development Agreement With Centre ofExcellence for Prevention of Organ Failure 296Table 160: Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex297Table 161: IRIS International Enters Into Distribution Agreement With Alifax 298Table 162: EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 299Table 163: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich ForPhenoFluor 301Table 164: Clovis Oncology Enters Into Co-Development Agreement With Array BioPharma302Table 165: RS Medical Enters Into Distribution Agreement With Harvest Technologies 303Table 166: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International304Table 167: Sandia National Labs Plans To Enter Into Licensing Agreement For SpinDx, Medical
  11. 11. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comDiagnostic Tool 305Table 168: HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck ForBreast Cancer Marker Patent Portfolio 306Table 169: Genisphere Enters Into Co-Development Agreement With Lankenau Institute forMedical Research 307Table 170: WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies308Table 171: Pacgen Enters Into Distribution Agreement With Arise Biotech For Pipettes 309Table 172: BioView Enters Into Co-Development Agreement With ScreenCell For CirculatingTumor Cell Analysis Technology 310Table 173: MDxHealth Enters Into Licensing Agreement With Merck For MGMT DiagnosticTest 311Table 174: Fluxion Biosciences Enters Into Co-Development Agreement With StanfordUniversity School of Medicine 313Table 175: Merrimack Pharma Enters Into Co-Development Agreement With Cancer TreatmentCenters of America 314Table 176: Phenomenome Discoveries Enters Into Licensing Agreement With Polymedco ForCancer Diagnostic Test 315Table 177: PlexPress Enters Into Technology Integration Agreement With Phalanx Biotech 316Table 178: PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 317Table 179: Kreatech Diagnostics Enters Into Co-Development Agreement With OridisBiomarkers For DNA-FISH Assays 319Table 180: Stratos Enters Into Co- Development Agreement With nanoMR 320Table 181: Guided Therapeutics Extends Licensing And Co-Development Agreement WithKonica Minolta 321Table 182: CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test322Table 183: Berg Pharma Enters Into Co-Development Agreement With Parkinsons Institute 323Table 184: Courtagen Life Sciences Enters Into Licensing Agreement With Scienion ForsciFlexArrayer Technology 324Table 185: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening ForAdenoPlus 325Table 186: Leica Microsystems Enters Into Integration Agreement With Indica Labs 327Table 187: Prolias Technologies Enters Into Licensing Agreement With Cornell University FormicroRNA Diagnostic Portfolio 328Table 188: Epigenomics Enters Into Licensing Agreement With Companion Dx Reference LabFor Septin9 Biomaker 329Table 189: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis330Table 190: Asuragen Enters Into Licensing Agreement With Becton, Dickinson 332Table 191: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4POC Test 333
  12. 12. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comTable 192: KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 334Table 193: Bruker Enters Into Research Agreement With Special Bacteriology ReferenceLaboratory 335Table 194: Bruker Enters Into Research Agreement With JMI Laboratories 337Table 195: RayBiotech Enters Into Agreement With Oslo University Hospital And University ofOslo 338Table 196: Vela Diagnostics Enters Into Co-Development Agreement With Eppendorf 340Table 197: One Lambda Enters Into Co-Marketing Agreement With CellTrend 341Table 198: ImaginAb Extends Licensing Agreement With Bzl Biologics For Imaging ProstateSpecific Membrane Antigen 342Table 199: Foundation Medicine Extends Co-Development Agreement With Novartis 343Table 200: Affymetrix Enters Into Co-Development Agreement With Massachusetts GeneralHospital For New Oncology Biomarker Tests 344Table 201: Fluxion Bioscience Enters Into Technology Integration Agreement With RubiconGenomics 345Table 202: Exosome Diagnostics Enters Into Technology Integration Agreement With LifeTechnologies 346Table 203: HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John WayneCancer Institute 347Table 204: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight GeneticsFor ALK Cancer Biomarker 348Table 205: Ventana Medical Enters Into Licensing Agreement With German Cancer ResearchCenter And University Hospital Heidelberg For BRAF V600E 349Table 206: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems351Table 207: Radisens Diagnostics Enters Into Co-Development Agreement With BeckmanCoulter For HDR Detection Technology 353Table 208: XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test354Table 209: Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL AnalyticalTechnology 356Table 210: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERGMarker 357Table 211: Affymetrix Enters Into Distribution Agreement With ScreenCell For CirculatingTumor Cell Technology 359Table 212: Exact Sciences Expands Licensing Agreement With Mayo Clinic 360Table 213: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 361Table 214: Dako Announces Licensing Agreement With Van Andel Research Institute ForCancer Diagnostic Tool 362Table 215: MicroFluidic Systems Enters Into Co-Development Agreement With University ofNevada 363Table 216: KineMed Enters Into Co-Development Agreement With CHDI Foundation 364
  13. 13. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comTable 217: ZyGem Enters Into Technology Integration Agreement With Quanta BioSciences 365Table 218: Pressure BioSciences Enters Into Co-Development Agreement With LeapTechnologies, Vici Valco Instruments And Sage-N Research 366Table 219: Islet Sciences Enters Into Licensing Agreement With Yale University For Early BetaCell Destruction and Diabetes Diagnostic 368Table 220: Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma369Table 221: Applied Microarrays Enters Into Co-Development Agreement With Sensovation ForFlexiPlex Array System 370Table 222: Cardinal Health Enters Into Distribution Agreement With Qiagen For MolecularDiagnostic Products 371Table 223: MetaStat Enters Into Licensing Agreement With Albert Einstein College of MedicineFor Metastatic Cell Technology Patents 372Table 224: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen ForLongRange PCR Kit 373Table 225: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 374Table 226: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery ForPressure Cycling Technology 375Table 227: Ezose Sciences Enters Into Co-Development Agreement With Hirosaki UniversityFor New Cancer Biomarkers 377Table 228: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 378Table 229: GE Healthcare Enters Into Co-Development Agreement With NXT2B For CompactCyclotron And PET Tracer System 379Table 230: Miraculins Enters Into Co-Marketing Agreement With Pear Healthcare Solutions ForPreVu 380Table 231: Abbott Enters Into Licensing Agreement With Stanford University For ProstateCancer Biomarkers 381Table 232: Metabolon Enters Into Co-Development Agreement With Takeda Pharma 383Table 233: Penn State Hershey Enters Into Co-Development Agreement With Serametrix 384Table 234: Sysmex Extends Distribution Agreement With Roche 385Table 235: Seattle Genetics And Millennium Pharma Enter Into Co-Development AgreementWith Ventana Medical Systems 387Table 236: Rubicon Genomics Enters Into Technology Integration Agreement With KreatechDiagnostics 389Table 237: NexDx Enters Into Licensing Agreement With University of California ForEpigenetic Biomarkers 390Table 238: Elchrom Scientific Enters Into Technology Integration Agreement With Biotium 391Table 239: RayBiotech Enters Into Co-Marketing Agreement With Innopsys 392Table 240: BGN Technologies Enters Into Licensing Agreement With Lauren Sciences For V-Smart Technology 393Table 241: Stellar Biotechnologies Enters Into Option Licensing Agreement With University ofGuelph For Clostridium Difficile Technology 394
  14. 14. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comTable 242: Shimadzu Scientific Instruments Enters Into Joint Venture Agreement WithUniversity of Texas 395Table 243: Centre of Excellence for Prevention of Organ Failure Enters Into Co-DevelopmentAgreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 396Table 244: Ridge Diagnostics Enters Into Licensing Agreement With Ameritox For MDDScore397Table 245: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 398Table 246: LabCorp Enters Into Licensing Agreement With OPKO Health For AlzheimersDiagnostic Technology 400Table 247: Accuray Enters Into Co-Development Agreement With University of Heidelberg 402Table 248: HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 403Table 249: GenMark Diagnostics Enters Into Co-Development Agreement With AdvancedLiquid Logic For Integrated Diagnostic Platform 404Table 250: PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics ForMicrofluidics Patent Portfolio 406Table 251: Bristol-Myers Squibb Enters Into Co-Development Agreement With Meso Scale 408Table 252: Applied BioCode Enters Into Licensing Agreement With Douglas Scientific ForBarcoded Magnetic Beads Technology 409Table 253: Molecular Response Enters Into Co-Marketing Agreement With Transparent 410Table 254: IBM Enters Into Co-Development Agreement With Memorial Sloan-KetteringCancer Center 411Table 255: QuantiScientifics Enters Into Co-Marketing Agreement With BioDot For A2MicroArray System 412Table 256: INOVA Diagnostics Enters Into Licensing Agreement With AmberGen AndMassachusetts General Hospital For Two Autoantigen Biomarkers 413Table 257: Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group ForLASEI DP-1000 415Table 258: Devicor Medical Products Enters Into Co-Marketing Agreement With CarbonMedical Technologies 416Table 259: Diomics Enters Into Licensing Agreement With University of Arizona For DNACollection Technology 417Table 260: Sage-N Research Enters Into Technology Integration Agreement With IO Informatics418Table 261: Mayo Medical Labs Enters Into Licensing Agreement With A&G Pharma ForProgranulin Blood Test 419Table 262: Abbott Enters Into Co-Development Agreement With Genetics Lab For MolecularAssay Development 420Table 263: Avedro Enters Into Option Agreement With Cleveland Clinic To License IntellectualProperty Assets 421Table 264: GE Global Research Enters Into Co-Development Agreement With InDevR 422Table 265: Roche Enters Into Licensing Agreement With Life Technologies For PCR
  15. 15. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comTechnology 423Table 266: Vital Diagnostics Enters Into Distribution Agreement With Cardinal Health 424Table 267: Dako Enters Into Co-Development Agreement With Amgen 425Table 268: Iverson Genetic Diagnostics Enters Into Co-Development Agreement WithVanderbilt University 426Table 269: RedHill Biopharma Enters Into Co-Development Agreement With Quest DiagnosticsTo Develop MAP Test For Crohns Disease 427Table 270: Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure ChemicalIndustries 428Table 271: Dolomite Centre Enters Into Co-Development Agreement With GigaGen 429Table 272: Mitomics Enters Into Co-Marketing Agreement With LabMD For Prostate CoreMitomic Test 430Table 273: Fresh Start Private Management Enters Into Licensing Agreement With Glacier 431Table 274: IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare432Table 275: Courtagen Life Sciences Enters Into Co-Development Agreement With Tetracore 433Table 276: Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership ToDevelop Tuberculosis Test 434Table 277: Avesthagen Enters Into Co-Development Agreement With CosmosID 436Table 278: Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiVHealthcare 437Table 279: Siemens Healthcare Diagnostics Enters Into Co-Development Agreement WithTocagen 439Table 280: Brooks Life Science Enters Into Licensing Agreement With The Scripps ResearchInstitute 441Table 281: SDIX Enters Into Licensing Agreement With BD Diagnostic 443Table 282: Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs444Table 283: DuPont Enters Into Co-Development Agreement With OligoCo 445Table 284: Genzyme Enters Into Co-Marketing Agreement With Veracyte 447Table 285: Boulder Diagnostics Enters Into Licensing Agreement With Portland State University448Table 286: Ventana Medical Systems Enters Into Co-Development Agreement With BayerPharma 449Table 287: Pressure BioSciences Enters Into Co-Marketing Agreement With Digilab 451Table 288: Agilent Technologies Enters Into Co-Development Agreement With IntegratedDiagnostics 453Table 289: Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 454Table 290: Ventana Medical Systems Enters Into Licensing Agreement With Cell SignalingTechnology 456Table 291: Dako Enters Into Co-Development Agreement With Amgen 458Table 292: Foundation Medicine Enters Into Co-Development Agreement With Sanofi For
  16. 16. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comGenetic Biomarkers And Potential Diagnostics 459Table 293: University Of North Dakota Enters Into Licensing Agreement With NeoMatrix 460Table 294: Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 461Table 295: Syndax Pharma Enters Into Co-Development Agreement With Ventana MedicalSystems 462Table 296: ZyGEM Enters Into Co-Development Agreement With USAMRIID 464Table 297: AEterna Zentaris Enters Into Co-Development Agreement With Ventana MedicalSystems 465Table 298: Boulder Diagnostics Enters Into Licensing Agreement With RUNMC 467Table 299: HistoRx Enters Into Licensing Agreement With Yale University 4681.2 List ofFiguresFigure 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 44Figure 2: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, 2004-2018 45Figure 3: In Vitro Diagnostics, North America, Cross-Category Analysis, 2004-2018 47Figure 4: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, Historic,2004-2011 49Figure 5: In Vitro Diagnostics, North America, Overall Revenue ($m), USD Constant, Forecast,2011-2018 51Figure 6: In Vitro Diagnostics, North America, Company share (%), 2011 53Figure 7: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, 2004-201855Figure 8: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Historic,2004-2011 57Figure 9: In Vitro Diagnostics, United States, Overall Revenue ($m), USD Constant, Forecast,2011-2018 59Figure 10: In Vitro Diagnostics, United States, Company Share (%), 2011 65Figure 11: Clinical Chemistry, United States, Company Share (%), 2011 67Figure 12: Genetic Testing, United States, Company Share (%), 2011 68Figure 13: Haematology, United States, Company Share (%), 2011 70Figure 14: Immuno Chemistry, United States, Company Share (%), 2011 72Figure 15: Infectious Immunology, United States, Company Share (%), 2011 74Figure 16: Microbiology Culture, United States, Company Share (%), 2011 76Figure 17: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, 2004-2018 78Figure 18: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 80Figure 19: In Vitro Diagnostics, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 82Figure 20: In Vitro Diagnostics, Canada, Company Share (%), 2011 88Figure 21: Clinical Chemistry, Canada, Company Share (%), 2011 90Figure 22: Genetic Testing, Canada, Company Share (%), 2011 92
  17. 17. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.comFigure 23: Haematology, Canada, Company Share (%), 2011 94Figure 24: Histology And Cytology, Canada, Company Share (%), 2011 96Figure 25: Immuno Chemistry, Canada, Company Share (%), 2011 98Figure 26: Infectious Immunology, Canada, Company Share (%), 2011 100Figure 27: Microbiology Culture, Canada, Company Share (%), 2011 102Figure 28: Siemens Healthcare, Company Share (%), North America In Vitro DiagnosticsMarket, 2011 104Figure 29: Abbott Laboratories, Company Share (%),North America In Vitro DiagnosticsMarket, 2011 105Figure 30: F. Hoffmann-La Roche Ltd., Company Share (%),North America In Vitro DiagnosticsMarket, 2011 106Figure 31: F. Hoffmann-La Roche Ltd., Company Share (%),North America In Vitro DiagnosticsMarket, 2011 107Figure 32: Ortho-Clinical Diagnostics Inc., Company Share (%),North America In VitroDiagnostics Market, 2011 108Figure 33: Alere Inc, Company Share (%),North America In Vitro Diagnostics Market, 2011 109 BUY NOW

×